Elan, Biogen to unveil data on drug to combat MS
A new drug could improve treatment of multiple sclerosis, early clinical trials suggest. On Saturday, Elan Corp. of Ireland and its U.S. partner, Biogen Inc., will announce long-awaited data from
A new drug could improve treatment of multiple sclerosis, early clinical trials suggest. On Saturday, Elan Corp. of Ireland and its U.S. partner, Biogen Inc., will announce long-awaited data from